In support of this hypothesis are the observations that carboxyhemoglobin production, a marker of hemolysis or RBC breakdown, is the same in G6PD Mediterranean deficient neonates with and without hyperbilirubinemia
Studies have shown that supplementing cobalamin in deficient cats experiencing gastrointestinal disease, like vomiting and diarrhea, has led to a significant improvement in GI signs, as well as weight gain
Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Peptide therapy is a potential treatment for osteoporosis, but understanding the risk factors and taking preventive measures such as lifestyle modifications is essential for preventing or slowing the progression of osteoporosis
Pharma giants Novo Nordisk and Pfizer also made sizable deals with Chinese drugmakers last year
These therapies target anhedonia and other depressive symptoms through different mechanisms
